Inflammation and neovascularization in diabetic atherosclerosis

Indian Journal of Experimental Biology

Volumn 45, Issue 1, 2007, Pages 93-102

  Purushothaman, K R ^a   Meerarani P , ^a   Moreno, P R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Hemorrhage; Neovessels

Indexed keywords

ALPHA DEFENSIN; DEFENSIN 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ARTERIOSCLEROSIS; DIABETIC ANGIOPATHY; DISEASE COURSE; HUMAN; INFLAMMATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ALPHA-DEFENSINS; ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 33847696161     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Evans J L, Goldfine I D, Maddux BA & Grodsky G M, Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr Rev, 5 (2002) 599
2. Fuster V, Moreno PR, Fayad Z A, Corti R & Badimon J J, Atherothrombosis and high-risk plaque: part I: evolving concepts, J Am Coll Cardiol, 46 (2005) 937.
3. Marette A, Pathogenic role of inflammatory cytokines in obesity: from insulin resistance to diabetes mellitus, Nestle Nutr Workshop Ser Clin Perform Programme, 9 (2004) 141.
4. Wild S, Roglic G, Green A, Sicree R & King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 27(2004) 1047.
5. Libby P, Inflammation in atherosclerosis, Nature, 420 (2002) 868.
6. Libby P, Ridker P M & Maseri A. Inflammation and atherosclerosis, Circulation; 105 (2002) 1135.
7. Fuster V, Badimon L, Badimon J J & Chesebro J H, The pathogenesis of coronary artery disease and the acute coronary syndromes (1), N Engl J Med, 326 (1992) 242.
8. Fuster V, Badimon L, Badimon J J, Chesebro J H, The pathogenesis of coronary artery disease and the acute coronary syndromes (2), N Engl J Med, 326 (1992) 310.
9. Ross R, The pathogenesis of atherosclerosis: a prospective for the 1990s, Nature, 362 (1993) 801.
10. Stary H C, Chandler A B, Dinsmore R E, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ & Wagner W D, A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Arterioscler Thromb Vasc Biol, 15 (1995) 1512.
11. Libby P. Vascular biology of atherosclerosis: overview and state of the art, Am J Cardiol. 91 (2003) 3A.
12. Ross R. Cell biology of atherosclerosis, Annu Rev Physiol, 57 (1995) 791.
13. Stitt A W, Bucala R & Vlassara H. Atherogenesis and advanced glycation: promotion, progression, and prevention, Ann N Y Acad Sci, 811 (1997) 115, discussion 127-1119
14. Hu F B, Stamfer M J, Solomon C G, Liu S, Willett W C, Speizer F E, Nathan D M & Manson J E, The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up, Arch Intern Med, 161 (2001) 1717.
15. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes. 44 (1995) 369.
16. Jay D, Hitomi H & Griendling K K, Oxidative stress and diabetic cardiovascular complications, Free Radic Biol Med, 40 (2006) 183.
17. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review), Int J Mol Med, 4 (1999) 223.
18. Mehta J L, Rasouli N, Sinha A K & Molavi B, Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction, Int J Biochem Cell Biol, 38 (2006) 794.
19. Dhindsa S, Tripathy D, Sanalkumar N, Ravishankar S, Ghanim H, Aljada A, Dandona P. Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment, J Clin Endocrinol Metab, 90 (2005) 5058.
20. Baynes J W & Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm, Diabetes, 48 (1999) 1.
21. Vlassara H, Recent progress in advanced glycation end products and diabetic complications, Diabetes 46 (1997), suppl 2, S19.
22. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H & Bucala R. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus, Am J Pathol, 143 (1993) 1649.
23. Yan S D, Schmidt A M, Anderson G M, Zhang J, Brett J, Zou Y S, Pinsky D & Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J Biol Chem, 269 (1994) 9889.
24. Ramana K V, Chandra D, Srivastava S, Bhatnagar A & Srivastava S K, Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells, Faseb J, 17 (2003) 417.
25. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M & Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A, J Biol Chem, 276 (2001) 25096.
26. Bouloumie A, Marumo T, Lafontan M, Busse R, Leptin induces oxidative stress in human endothelial cells, Faseb J, 13 (1999) 1231.
27. Burke A P, Kolodgie F D, Zieske A, Fowler D R, Weber D K, Varghese P J, Farb A, Virmani R, Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study, Arterioscler Thromb Vasc Biol, 24 (2004) 1266.
28. Purushothaman K R, O'Connor W N, Echeverri D, Amadi C, Badimon J J, Fuster V & Moreno P R, Ruptured Diabetic Atherosclerotic Plaques Have More Inflammation and Neovascularization Than Ruptured Plaques From Patients Without Diabetes, J Am Coll Cardiol, 43 (2004), Supp A 496A.
29. Purushothaman K R Fuster V, Sirol M, O'Connor W N, Hutter R , Sharma S K & Moreno P R, Intra-Plaque Hemorrhage In Diabetic Atherosclerosis Is Characterized by Increased Microvessel Complexity, Intra-luminal Macrophages, and Intra-luminal Red Blood Cells, J Am Coll Cardiol, 47 (2006) 331A.
30. Purushothaman K R MorenoP, O'Connor W N, Kini A S, Sharma S K, Fuster V, Histological Evidence for Atherosclerotic Neovascularization as a Pathway for Macrophage Infiltration in Diabetes Mellitus, J Am Coll Cardiol, 45 (2005) 439A.
31. Kol A, Sukhova G K, Lichtman A H & Libby P, Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation, 98 (1998) 300.
32. Strachan D P, Carrington D, Mendall M A, Ballam L, Morris J, Butland B K, Sweetnam P M & Elwood P C, Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study, Bmj, 318 (1999) 1035.
33. Liuzzo G & Rizzello V, C-reactive protein and primary prevention of ischemic heart disease, Clin Chim Acta, 311 (2001) 45.
34. Hayden M R, Tyagi S C, Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation, Cardiovasc Diabetol, 3 (2004) 1.
35. Purushothaman K R, Echeverri D, Fuster V, O'Connor W N & Moreno P R. Neovascularization, inflammation and intraplaque hemorrhage are increased in advanced human atherosclerosis from patients with diabetes mellitus, Circulation, 108 (2003) 459.
36. Lu H, Raptis M, Black E, Stan M, Amar S & Graves D T, Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue, Endocrinology, 145 (2004) 4934.
37. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R & Adamis A P, Advanced glycation end products increase retinal vascular endothelial growth factor expression, J Clin Invest, 101 (1998) 1219.
38. Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H & Kondo M, Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells, Biochem Biophys Res Commun, 236 (1997): 712.
39. Hovind P, Tarnow L, Oestergaard P B & Parving H H, Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy, Kidney Int Suppl, 75 (2000) S56.
40. Studer P P, [Metabolic control and angiopathy in diabetes: vascular changes in animals with induced hyperglycemia, its relationship on human diabetes (author's transl)], SchweizRundsch Med Prax, 68 (1979) 1630.
41. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G, Leukocyteendothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion, J Clin Invest, 101 (1998) 1905.
42. Anghelina M, Krishnan P, Moldovan L & Moldovan NI. Monocytes and macrophages form branched cell columns in matrigel: implications for a role in neovascularization, Stem Cells Dev, 13 (2004) 665.
43. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K & Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis, Proc Natl Acad Sci USA, 100 (2003) 4736.
44. Moulton K S, Heller E, Konerding M A, Flynn E, Palinski W, Folkman J, Angiogenesis inhibitors endostatin or TNP- 470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice, Circulation, 99 (1999) 1726.
45. Creager M A, Luscher T F, Cosentino F & Beckman J A, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I, Circulation, 108 (2003) 1527.
46. Semenza G L, Expression of hypoxia-inducible factor 1: mechanisms and consequences, Biochem Pharmacol, 59 (2000) 47.
47. North S, Moenner M, Bikfalvi A, Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors, Cancer Lett, 218 (2005) 1.
48. Moreno P R, Purushothaman K R, Fuster V, Echeverri D, Truszczynska H, Sharma S K, Badimon J J & O'Connor W N, Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability, Circulation, 110 (2004) 2032.
49. Moreno P R, Purushothaman K R, O'Connor W N, Kini A S, Sirol M, Sharma S K & Fuster V. Increased Inflammation and Neovascularization in Diabetic Atherosclerosis is no Longer Present in Fibrocalcific Plaques: A Marker of Stabilization? J Am Coll Cardiol, 45 (2005) 402A.
50. Purushothaman K R, Fuster V, O'Connor, W N & Moreno P R, Neovascularization is the most powerful independent predictor for progression to disruption in high-risk atherosclerotic plaques, J Am Coll Cardiol, 41 (2003) 352A.
51. Levy A P, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul F M & Skorecki K, Haptoglobin phenotype and vascular complications in patients with diabetes, N Engl J Med, 343 (2000) 969.
52. Levy A P, Hochberg I, Jablonski K, Resnick H E, Lee E T, Best L, Howard B V, Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study, J Am Coll Cardiol, 40 (2002) 1984.